These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

760 related items for PubMed ID: 27021328

  • 21. Identification, antifungal resistance profile, in vitro biofilm formation and ultrastructural characteristics of Candida species isolated from diabetic foot patients in Northern India.
    Kumar D, Banerjee T, Chakravarty J, Singh SK, Dwivedi A, Tilak R.
    Indian J Med Microbiol; 2016; 34(3):308-14. PubMed ID: 27514952
    [Abstract] [Full Text] [Related]

  • 22. [Multicenter study of fungemia due to yeasts in Argentina].
    Rodero L, Davel G, Soria M, Vivot W, Córdoba S, Canteros CE, Saporiti A, EMIFN.
    Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638
    [Abstract] [Full Text] [Related]

  • 23. Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil.
    Ramos LS, Figueiredo-Carvalho MH, Barbedo LS, Ziccardi M, Chaves AL, Zancopé-Oliveira RM, Pinto MR, Sgarbi DB, Dornelas-Ribeiro M, Branquinha MH, Santos AL.
    J Antimicrob Chemother; 2015 Jan; 70(1):111-5. PubMed ID: 25134720
    [Abstract] [Full Text] [Related]

  • 24. Mechanism of berberine-mediated fluconazole-susceptibility enhancement in clinical fluconazole-resistant Candida tropicalis isolates.
    Shi G, Shao J, Wang T, Wu D, Wang C.
    Biomed Pharmacother; 2017 Sep; 93():709-712. PubMed ID: 28700974
    [Abstract] [Full Text] [Related]

  • 25. Decreasing fluconazole susceptibility of clinical South African Cryptococcus neoformans isolates over a decade.
    Naicker SD, Mpembe RS, Maphanga TG, Zulu TG, Desanto D, Wadula J, Mvelase N, Maluleka C, Reddy K, Dawood H, Maloba M, Govender NP, for GERMS-SA.
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008137. PubMed ID: 32231354
    [Abstract] [Full Text] [Related]

  • 26. In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program.
    Pfaller MA, Messer SA, Boyken L, Hollis RJ, Rice C, Tendolkar S, Diekema DJ.
    Diagn Microbiol Infect Dis; 2004 Mar; 48(3):201-5. PubMed ID: 15023430
    [Abstract] [Full Text] [Related]

  • 27. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M, Karaman M.
    Mikrobiyol Bul; 2004 Mar; 38(1-2):91-8. PubMed ID: 15293907
    [Abstract] [Full Text] [Related]

  • 28. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
    Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, Meis JF, Chowdhary A.
    J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
    [Abstract] [Full Text] [Related]

  • 29. A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species.
    Bongomin F, Oladele RO, Gago S, Moore CB, Richardson MD.
    Mycoses; 2018 May; 61(5):290-297. PubMed ID: 29377368
    [Abstract] [Full Text] [Related]

  • 30. In Vitro Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017.
    Pfaller MA, Huband MD, Flamm RK, Bien PA, Castanheira M.
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182527
    [Abstract] [Full Text] [Related]

  • 31. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA, Diekema DJ, Boyken L, Tendolkar S, Hollis RJ, Pfaller MA.
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods.
    Pfaller MA, Boyken L, Hollis RJ, Messer SA, Tendolkar S, Diekema DJ.
    J Clin Microbiol; 2005 Aug; 43(8):3807-10. PubMed ID: 16081915
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods.
    Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Diekema DJ.
    J Clin Microbiol; 2007 Jan; 45(1):70-5. PubMed ID: 17079501
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.